5574
J. A. Pérez-Bautista et al. / Tetrahedron Letters 50 (2009) 5572–5574
was stirred for 6 h. When the consumption of the starting aziridine was
completed (monitored by TLC), the reaction mixture was quenched with water
(50 mL) and the organic phase was extracted with ethyl acetate (3 ꢂ 50 mL).
The combined organic layers were dried with anhydrous Na2SO4 and
concentrated under reduced pressure. The yellow oil residue was purified by
flash silica gel chromatography (eluent:hexane/ethyl acetate 30:1). (1S,2S,10S)-
[(10-Phenylethyl)-(2-phenylselenyl-cyclohexyl)amine]; (1S,2S,10S)-8: Yield 86%;
keeping the dialdehyde in a chloroform solution for several days at
room temperature (inside NMR tube), a small amount of the con-
densation product is formed.
In conclusion, we are pleased to report the first selective intra-
molecular aldol-condensation catalyzed by an internal base, which
is based on an internal hydrogen bonding. The enormous utility of
this reaction was showcased in the synthesis of optically pure
½ ꢃ
a 2D0 = +69.23 (c = 2.0, CHCl3); 1H NMR (CDCl3, 400 MHz) d: 1.01 (m, 1H), 1.16
(m, 2H), 1.33 (d, 3H, J = 6.8 Hz), 1.53 (m, 3H), 1.81 (m, 1H), 2.08 (m, 2H), 2.53
(td, 1H, J = 9.6, 4.0 Hz), 3.01 (m, 1H), 3.82 (q, 1H, J = 6.4 Hz), 7.14–7.29 (m, 8H),
7.54 (m, 2H); 13C NMR (CDCl3, 100 MHz) d: 24.2, 24.4, 26.7, 33.7, 33.8, 50.8,
56.5, 59.4, 126.3, 126.4, 127.3, 128.7, 135.1, 146.8; HRMS (EI) m/z found
359.1140, calcd. for C20H25NSe 359.1152. (1R,2R,10S)-[(10-Phenyl-ethyl)-(2-
N-protected
responding
c
c
-aminocyclopentene aldehyde (1S,10S)-1 and its cor-
-amino acid (1S,10S)-2. Although this route was exclu-
sively designed for the synthesis of the above-mentioned GABA
and nucleoside precursors, we expect that these results can also
phenylselenyl-cyclohexyl)]amine; (1S,2S,10S)-9: Yield 8%; ½a 2D0
= ꢀ82.72 (c = 1.8,
ꢃ
CHCl3); 1H NMR (CDCl3, 400 MHz) d: 1.10 (m, 1H), 1.17–1.33 (m, 2H), 1.35 (d,
3H, J = 6.9 Hz), 1.53–1.63 (m, 2H), 2.03 (m, 2H), 2.13–2.26, (m, 2H) 2.43(s, 1H),
3.04 (ddd, 1H, J = 11.7, 9.9, 3.9 Hz), 3.93 (q, 1H, J = 6.6 Hz), 7.15–7.42 (m, 10H);
13C NMR (CDCl3, 100 MHz) d: 24.3, 24.9, 27.1, 32.2, 34.1, 51.0, 54.1, 56.8, 126.6,
126.8, 127.4, 128.4, 128.8, 135.3, 145.2. HRMS (EI) m/z found 359.1151, calcd.
for C20H25NSe 359.1152.
be applied to the synthesis of further complex substituted
c-
aminocyclopentene derivatives. Further results on the application
of this new route for the synthesis of new GABA, and nucleosides
derivatives will be reported soon.
13.
A similar negative effect on the yields and stereoselective outcome of
aziridines ring-opening with azide was observed in: Chandrasekhar, M.;
Acknowledgments
Sekar, G.; Singh, V. K. Tetrahedron Lett. 2000, 41, 10079.
14. Crystal data: C20H26ClNSe, Mr = 394.83 gmolꢀ1
,
0.10 ꢂ 0.28 ꢂ 0.60 mm3,
We thank CONACyT for financial support (grants: 62203 and
91435 for FSP and MSR, respectively). We also thank Mr. Vladimir
Carranza-Tellez for technical assistance.
triclinic, space group P-1, T = 293(2) K, a = 7.5474(9), b = 9.0498(11)
c =16.145(2) Å,
Z = 2, calcd = 1.347,
independent reflections (Rint = 0.038), R1 = 0.075 for 6002 reflections with I >2
(I) and wR2 = 0.173 for all data, 411 parameters, GOF = 1.16 (CCDC 723281).
a
= 99.491(2), b = 97.620(2),
l
c
= 113.462(2) °, V = 973.5(2) Å3,
q
= 2.066 mmꢀ1, 2hmax = 25.00, 9488 measured and 6734
r
References and notes
15. (a) Selenium in Natural Products Synthesis; Nicolaou, K. C., Petasis, N. A., Eds.;
CIS, Inc., 1984. Chapter 4; (b) Nishibayashi, Y.; Uemura, S. In Organoselenium
Chemistry–A Practical Approach; Back, T. G., Ed.; Oxford University Press:
Oxford, 1999; p Chapter 11; (c) Nishibayashi, Y.; Uemura, S.. In Topics in Current
Chemistry: Organoselenium Chemistry; Wirth, T., Ed.; Springer: Berlin, 2000; Vol.
208, p 201.
1. (a) Coe, D. M.; Parry, D. M.; Roberts, S. M.; Storer, R. J. Chem. Soc., Perkin Trans. 1
1991, 2373; (b) Vanhessche, K.; Gonzalez Bello, C.; Vandewalle, M. Synlett
1991, 921; (c) Borthwick, A. D.; Biggadike, K. Tetrahedron 1992, 48, 571; (d)
Agrofoglio, L.; Suhas, E.; Farese, A.; Condom, R.; Challand, S. R.; Earl, R. A.;
Guedj, R. Tetrahedron 1994, 50, 10611.
2. (a) Marquez, V. E.; Lim, M.-I. Med. Res. Rev. 1986, 6, 1; (b) Rodriguez, J. B.;
Marquez, V. E.; Nicklaus, M. C.; Mitsuya, H.; Barchi, J. J. J. Med. Chem. 1994, 37,
3389; (c) Ferrero, M.; Gotor, V. Chem. Rev. 2000, 100, 4319; (d) An, G.; Rhee, H.
Nucleotides Nucleic Acids 2002, 21, 65.
3. (a) Bergmeir, S. C.; Cobas, A. A.; Rapoport, H. J. Org. Chem. 1993, 58, 2369; (b)
Qiu, J.; Pingsterhaus, J. M.; Silverman, R. B. J. Med. Chem. 1999, 42, 4727; (c)
Ordoñez, M.; Cativiela, C. Tetrahedron: Asymmetry 2007, 18, 3.
4. Marquez, V. E.; Lim, B. B.; Barchi, J. J., Jr.; Nicklaus, M. C. Conformational Studies
and Anti-HIV Activity of Mono- and Difluorodideoxy Nucleosides. In
Nucleosides and Nucleotides as Antitumor and Antiviral Agents; Chu, C. K.,
Baker, D. C., Eds.; Plenum Press: New York and London, 1993; p 265.
5. Chebib, M.; Duke, R. K.; Allan, R. D.; Johnston, G. A. R. Eur. J. Pharmacol. 2001,
430, 185.
6. (a) Rodríguez, V.; Sánchez, M.; Quintero, L.; Sartillo-Piscil, F. Tetrahedron 2004,
60, 10809; (b) Rodríguez, V.; Quintero, L.; Sartillo-Piscil, F. Tetrahedon Lett.
2007, 48, 4305; (c) Rodríguez, V.; Quintero, L.; Sartillo-Piscil, F. Tetrahedon
2008, 64, 2750.
7. (a) Romero, M.; Hernández, L.; Quintero, L.; Sartillo-Piscil, F. Carbohydr.
Res. 2006, 341, 2883; (b) Valdivia, V.; Hernández, A.; Rivera, A.; Sartillo-
Piscil, F.; Loukaci, A.; Fourrey, J.-L.; Quintero, L. Tetrahedron Lett. 2005, 46,
6511.
8. De Parrodi, C. A.; Moreno, G. E.; Quintero, L.; Juaristi, E. Tetrahedron: Asymmetry
1998, 9, 2093.
9. (a) Zhang, W.-X.; Ye, K.; Ruan, S.; Chen, Z.-X.; Xia, Q.-H. Chin. J. Chem. 2007, 25,
1758; (b) Besev, M.; Engman, L. Org. Lett. 2000, 2, 1589; (c) Braga, A. L.; Lüdtke,
D. S.; Paixão, M. W.; Rodriguez, O. E. D. Org. Lett. 2003, 5, 2635; (d) Braga, A. L.;
Paixão, M. W.; Marin, G. Synlett 2005, 11, 1675.
16. Sequential dihydroxylation–dehomologation-aldol-condensation of allyl amine
(1S,10S)-7: To
10 mL of
a
solution of allyl amine (1S,10S)-7 (0.050 g, 0.17 mmol) in
mixture of acetone/H2O (10/1), 4-methylmorpholine N-oxide
a
(0.060 g, 0.51 mmol) and osmium tetroxide (0.0034 mmol, 0.034 mL of a 0.1 M
tert-butanol solution) were added. The resulting solution was stirred for 16 h at
room temperature. When the consumption of the starting amine was
completed (monitored by TLC), the reaction mixture was quenched with
water (20 mL) and the organic phase was extracted with CH2Cl2 (3 ꢂ 30 mL).
The combined organic layers were dried with anhydrous Na2SO4, filtered, and
the solvent was evaporated carefully under reduced pressure. The residue was
dissolved in ethanol (10 mL) and sodium periodate (0.07 g, 0.32 mmol) was
slowly added at 0 °C. The reaction mixture was allowed to react for 2 h and
filtered, whereupon the solvent was evaporated carefully under reduced
pressure and the residue extracted with CH2Cl2 (50 mL). The organic layer was
washed with water and brine, dried with Na2SO4, and concentrated under
reduced pressure. The crude product was purified by flash chromatography on
silica gel (eluent:hexane/ethyl acetate 5:1) to afford the c-aminocyclopentene
aldehyde (1S,10S)-1 in 60% yield; ½a 2D0
ꢃ
ꢀ84.66 (c 0.03, CHCl3); 1H NMR d: 1.40
(d, 3H, J = 6.6 Hz), 1.90–2.00 (m, 1H), 2.07–2.18 (m, 1H), 2.28–2.39 (m, 1H),
2.55 (m, 1H), 3.67 (q, 2H, J = 15.0 Hz), 3.91 (q, 1H, J = 6.9 Hz), 4.28 (m, 1H,), 6.42
(s, 1H), 7.23 (m, 4H), 7.24–7.42 (m, 6H), 9.62 (s, 1H); 13C NMR (CDCl3,
100 MHz) d: 6.1, 16.7, 26.9, 50.9, 57.6, 64.2, 126.8, 126.9, 127.6, 128.2, 128.3,
154.9, 158.1, 189.8; HRMS (FAB+) m/z found 305.1887, calcd. for C21H23NO,
305.1780. The corresponding c
-aminocyclopentene acid (1S,1S0)-2 is obtained
when 2 equiv of Jones reagent is added into the flask containing the (1S,10S)-1
reaction crude. Purification by flash chromatography on silica gel
(eluent:hexane/ethyl acetate 3:1) afforded the
c-aminocyclopentene acid
(1S,10S)-2 in 52% yield. White solid, mp 127–128 °C; ½a 2D0
ꢀ171.6 (c 1.0,
ꢃ
CHCl3). 1H NMR d: 1.25 (s, 2H), 1.35 (d, 3H, J = 6.6 Hz), 1.88–2.00 (m, 1H), 2.04–
2.17 (m, 1H), 2.35–2.45 (m, 1H), 2.57 (m, 1H), 3.67 (q, 2H, J = 15 Hz), 3.88
(q, 1H, J = 6.6 Hz), 4.19 (m, 1H,), 6.57 (s, 1H), 7.23 (m, 4H), 7.28–7.42 (m, 6H);
13C NMR d: 16.6, 27.4, 29.9, 50.7, 57.5, 64.4, 126.7, 126.8, 127.6, 128.1, 128.2,
128.3, 135.9, 141.2, 143.9, 148.8, 170.1 HRMS (EI) m/z found 322.1804, calcd.
for C21H23NO2, 322.1807.
10. (a) Heathcock, C. H.. In Comprensive Organic Synthesis; Trost, B., Ed.; Pergamon:
Oxford, 1991; Vol. 2, p 156; (b) Corey, E. J.; Danheiser, R. L.; Chandrasekaran, S.;
Siret, P.; Keck, G. E.; Gras, J.-L. J. Am. Chem. Soc. 1978, 100, 8031; (c) Woodward,
R. B.; Sondheimer, F.; Taub, D.; Heusler, K.; McLamore, W. M. J. Am. Chem. Soc.
1952, 74, 4223; (d) Snyder, S. A.; Corey, E. J. Tetrahedron Lett. 2006, 47, 2083.
11. Sharpless, K. B.; Lauer, R. F. J. Am. Chem. Soc. 1973, 95, 2697.
12. Stereoselective ring-opening of N-[(S)-1-phenylethyl]cyclohexyl aziridine (1S)-5
17. (1S,10S)-[(N-1,4-Diformylbutyl)-N-(10 phenylethyl)]acetamide; (1S, 10S)-12: 1H
NMR d: 1.55–1.82 (m, 2H), 1.67 (d, 3H, J = 7.2 Hz), 2.29 (m, 2H), 2.36 (s, 3H),
2.48 (q, 2H, J = 6.4 Hz), 2.99 (dd, 1H, J = 8.0, 4.4 Hz), 5.22 (q, 1H, J = 7.2 Hz), 7.37
(m, 5H), 9.06 (s, 1H), 9.77 (s, 1H); 13C NMR (CDCl3, 100 MHz) d: 18.2, 20.0, 29.2,
43.7, 56.3, 61.6, 127.0, 128.4, 129.0, 139.2, 170.6, 198.6, 202.1.
with phenylselenide anion: To
a solution of diphenyldiselenide (2.33 g,
7.45 mmol) and sodium borohydride (1.13 g, 19.84 mmol) in methanol
(50 mL) at 0 °C, N-[(S)-1-phenylethyl]cyclohexyl aziridine (S)-58 (1 g,
4.96 mmol) dissolved in methanol (15 mL) was added. The resulting solution